155 related articles for article (PubMed ID: 18284822)
1. Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice.
Pan SY; Dong H; Zhao XY; Xiang CJ; Fang HY; Fong WF; Yu ZL; Ko KM
J Pharm Pharmacol; 2008 Mar; 60(3):399-403. PubMed ID: 18284822
[TBL] [Abstract][Full Text] [Related]
2. Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate.
Pan SY; Dong H; Guo BF; Zhang Y; Yu ZL; Fong WF; Han YF; Ko KM
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):585-91. PubMed ID: 21523558
[TBL] [Abstract][Full Text] [Related]
3. Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in mice.
Zhang Y; Zhao J; Zhou SF; Yu ZL; Wang XY; Zhu PL; Chu ZS; Pan SY; Xie M; Ko KM
Lipids Health Dis; 2017 Jan; 16(1):8. PubMed ID: 28086886
[TBL] [Abstract][Full Text] [Related]
4. Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice.
Pan SY; Yang R; Dong H; Yu ZL; Ko KM
Eur J Pharmacol; 2006 Dec; 552(1-3):170-5. PubMed ID: 17046746
[TBL] [Abstract][Full Text] [Related]
5. Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice.
Pan SY; Dong H; Yu ZL; Zhao XY; Xiang CJ; Wang H; Fong WF; Ko KM
J Pharm Pharmacol; 2007 Dec; 59(12):1657-62. PubMed ID: 18053327
[TBL] [Abstract][Full Text] [Related]
6. A novel experimental model of acute hypertriglyceridemia induced by schisandrin B.
Pan SY; Dong H; Han YF; Li WY; Zhao XY; Ko KM
Eur J Pharmacol; 2006 May; 537(1-3):200-4. PubMed ID: 16624278
[TBL] [Abstract][Full Text] [Related]
7. Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice.
Zhang Y; Pan SY; Zhou SF; Wang XY; Sun N; Zhu PL; Chu ZS; Yu ZL; Ko KM
Drug Des Devel Ther; 2014; 8():1429-39. PubMed ID: 25278745
[TBL] [Abstract][Full Text] [Related]
8. A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice.
Chu ZS; Yu ZL; Pan SY; Jia ZH; Wang XY; Zhang Y; Zhu PL; Wang XJ; Ko KM
Lipids Health Dis; 2015 Aug; 14():93. PubMed ID: 26303027
[TBL] [Abstract][Full Text] [Related]
9. Novel mouse model of combined hyperlipidemia associated with steatosis and liver injury by a single-dose intragastric administration of schisandrin B/cholesterol/bile salts mixture.
Pan SY; Jia ZH; Zhang Y; Yu Q; Wang XY; Sun N; Zhu PL; Yu ZL; Ko KM
J Pharmacol Sci; 2013; 123(2):110-9. PubMed ID: 24096833
[TBL] [Abstract][Full Text] [Related]
10. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin B attenuates acetaminophen-induced hepatic injury through heat-shock protein 27 and 70 in mice.
Li L; Zhang T; Zhou L; Zhou L; Xing G; Chen Y; Xin Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):640-7. PubMed ID: 24219791
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined dietary supplementation with fenofibrate and Schisandrae Fructus pulp on lipid and glucose levels and liver function in normal and hypercholesterolemic mice.
Zhu PL; Pan SY; Zhou SF; Zhang Y; Wang XY; Sun N; Chu ZS; Yu ZL; Ko KM
Drug Des Devel Ther; 2015; 9():923-35. PubMed ID: 25733812
[TBL] [Abstract][Full Text] [Related]
13. [Dual effects of extract of Schisandra chinensis Baill on rat hepatic CYP3A].
Chen Q; Wu YJ; Cheng NN; Li YL; Wang YM
Yao Xue Xue Bao; 2010 Sep; 45(9):1194-8. PubMed ID: 21351579
[TBL] [Abstract][Full Text] [Related]
14. Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice.
Giridharan VV; Thandavarayan RA; Sato S; Ko KM; Konishi T
Free Radic Res; 2011 Aug; 45(8):950-8. PubMed ID: 21615274
[TBL] [Abstract][Full Text] [Related]
15. Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
Thandavarayan RA; Giridharan VV; Arumugam S; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
PLoS One; 2015; 10(3):e0119214. PubMed ID: 25742619
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective effect of Schisandra chinensis (Turcz.) Baill. lignans and its formula with Rubus idaeus on chronic alcohol-induced liver injury in mice.
Wang O; Cheng Q; Liu J; Wang Y; Zhao L; Zhou F; Ji B
Food Funct; 2014 Nov; 5(11):3018-25. PubMed ID: 25255087
[TBL] [Abstract][Full Text] [Related]
17. Preventive Effects of Schisandrin A, A Bioactive Component of
Yeon M; Choi H; Jun HS
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32354126
[TBL] [Abstract][Full Text] [Related]
18. Dietary pulp from Fructus Schisandra Chinensis supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice fed a normal or high cholesterol/bile salt diet.
Sun N; Pan SY; Zhang Y; Wang XY; Zhu PL; Chu ZS; Yu ZL; Zhou SF; Ko KM
Lipids Health Dis; 2014 Mar; 13():46. PubMed ID: 24621253
[TBL] [Abstract][Full Text] [Related]
19. Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity.
Pan SY; Yu Q; Zhang Y; Wang XY; Sun N; Yu ZL; Ko KM
Lipids Health Dis; 2012 Sep; 11():120. PubMed ID: 22989092
[TBL] [Abstract][Full Text] [Related]
20. Long-term schisandrin B treatment mitigates age-related impairments in mitochondrial antioxidant status and functional ability in various tissues, and improves the survival of aging C57BL/6J mice.
Ko KM; Chen N; Leung HY; Leong EP; Poon MK; Chiu PY
Biofactors; 2008; 34(4):331-42. PubMed ID: 19850987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
